Last Updated: 2026

Natco Pharma

Rank#4725

Market Cap2.08B

CountryIndia

Summary

NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF; and agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. The company markets its products in approximately 50 countries. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

History

Natco Pharma was founded in 1981 in Hyderabad, Telangana. It started as a small active pharma chemicals manufacturer and gradually emerged as one of the leading Indian pharmaceutical companies specializing in oncology, diabetes, and pain management products. Natco has gained immense success in the Indian pharmaceutical market.

Mission

To develop and market innovative and quality products of international standards in order to enhance the quality of life of both individuals and entire communities.

Vision

To develop into a premier global pharmaceutical organisation and a key partner in the search for new, cost effective medicines and therapies.

References

https://en.wikipedia.org/wiki/Natco_Pharma

https://in.investing.com/equities/natco-pharma-ltd

https://finance.yahoo.com/quote/NATCOPHARM.NS/profile?p=NATCOPHARM.NS

https://www.crunchbase.com/organization/natco-pharma

https://companiesmarketcap.com/

https://www.natcopharma.co.in

Leadership team

Mr. S. V. V. N. Appa Rao (Chief Financial Officer)

Mr. Rajeev Nannapaneni (CEO & Director)

Dr. Donthineni Linga Rao M.D. (Pres of Technical Affairs & Whole Time Director)

Products / Services

Health Care, Manufacturing, Medical

Number of Employees

1,000 - 20,000

Address

Hyderabad, Andhra Pradesh, India

Established

1995-01-01

Net Income

S_20M_100M

Revenue

100M - 500M

Traded as

NATCOPHARM.NS

Website

https://www.natcopharma.co.in

Social Media

Last Updated: 2026

Natco Pharma

Rank#4725

Market Cap2.08B

CountryIndia

Summary

History

Mission

To develop and market innovative and quality products of international standards in order to enhance the quality of life of both individuals and entire communities.

Vision

To develop into a premier global pharmaceutical organisation and a key partner in the search for new, cost effective medicines and therapies.

References

https://en.wikipedia.org/wiki/Natco_Pharma

https://in.investing.com/equities/natco-pharma-ltd

https://finance.yahoo.com/quote/NATCOPHARM.NS/profile?p=NATCOPHARM.NS

https://www.crunchbase.com/organization/natco-pharma

https://companiesmarketcap.com/

https://www.natcopharma.co.in

Leadership team

Mr. S. V. V. N. Appa Rao (Chief Financial Officer)

Mr. Rajeev Nannapaneni (CEO & Director)